4//SEC Filing
PIERIS PHARMACEUTICALS, INC. 4
Accession 0000899243-17-006558
$PVLACIK 0001583648operating
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:50 AM ET
Size
5.6 KB
Accession
0000899243-17-006558
Insider Transaction Report
Form 4
Matis Louis
SVP, Chief Development Officer
Transactions
- Award
Stock option (Right to buy)
2017-02-23+145,000→ 145,000 totalExercise: $1.99Exp: 2027-02-23→ Common Stock (145,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on January 1, 2018 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.
Documents
Issuer
PIERIS PHARMACEUTICALS, INC.
CIK 0001583648
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001583648
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:50 AM ET
- Size
- 5.6 KB